On this page Agenda Applications for consideration at this meeting 1172.1 Testing for BRAF mutation in patients with metastatic melanoma for access to vemurafenib (resubmission) 1344.1 Assessment of foot and ankle services by podiatric surgeons (resubmission) 1361.2 Transcatheter Aortic Valve Implantation via Transfemoral or Transapical Delivery (resubmission) 1365.1 Active middle ear implants for sensorineural hearing loss (resubmission) 1366 Transient Elastography at 50Hz for the diagnosis of Liver Fibrosis in patients with confirmed Hepatitis B or confirmed Hepatitis C 1370 Ocriplasmin for symptomatic vitreomacular adhesion (sVMA) including macular hole 1377 Optical coherence tomography (OCT) for retinal assessment in the presence of diabetic macular oedema (DMO) for access to treatment with dexamethasone posterior segment drug delivery system 1380 BRCA mutation testing to determine eligibility for olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer 1385 Shared Medical Appointments (SMAs) for Type 2 Diabetes Management 1411.1 Genetic testing for hereditary mutations predisposing to cancer (breast and/or ovarian) (resubmission) Related information Committee: Medical Services Advisory Committee (MSAC)